Tag: Generics
The Undetected Elephant in the Room: An Analysis of DG Competition’s...
This article is part of a Chronicle. See more from this Chronicle
Anthony Dawes, James Killick, Feb 24, 2009
On November 28, 2008, DG Competition's ("DG...
EC’s Preliminary Pharmaceutical Sector Report: An Aggressive Review of Industry Conduct
This article is part of a Chronicle. See more from this Chronicle
Susan Creighton, Seth Silber, Feb 24, 2009
This commentary explores the potential impact of...
The Interplay of Patenting Strategies and Competition Law in the Pharmaceutical...
This article is part of a Chronicle. See more from this Chronicle
Kristina Nordlander, Stephen Spinks, Feb 24, 2009
In the presentation of its Preliminary Report...
Pharmaceuticals Sector Inquiry: The European Commission Presents Its Preliminary Findings
This article is part of a Chronicle. See more from this Chronicle
Elena Kamilarova, Dominik Schnichels, Feb 24, 2009
On November 28, 2008 the European Commission...
From Walker Process to In re DDAVP: Should Direct Purchasers Have...
This article is part of a Chronicle. See more from this Chronicle
Aidan Synnott, Nov 29, 2008
In In re: DDAVP Direct Purchaser Antitrust Litigation, decided...
The EC Pharmaceutical Inquiry: Behind the Headlines, What is the Real...
This article is part of a Chronicle. See more from this Chronicle
Thomas Cueni, Nov 12, 2008
While the pharmaceutical sector waits for the European Commission's...
The Pharmaceutical Inquiry: Anything to Report?
This article is part of a Chronicle. See more from this Chronicle
Sean-Paul Brankin, Nov 12, 2008
One reaction to the pharmaceuticals sector inquiry, particularly from...
The EC’s Investigation into the Pharmaceutical Sector: Trouble Ahead at the...
This article is part of a Chronicle. See more from this Chronicle
David Hull, Nov 12, 2008
Efforts by innovative pharmaceutical companies to protect their markets...
Innovation Markets after Genzyme/Novazyme
This article is part of a Chronicle. See more from this Chronicle
Richard Gilbert, Jul 12, 2008
The U.S. Federal Trade Commission alleged adverse effects on...
Comment on the EC’s Pharmaceutical Dawn Raids
This article is part of a Chronicle. See more from this Chronicle
Susan Creighton, Scott Russell, Feb 14, 2008
The pharmaceutical industry remains under close examination...